Stock Events

Stock Events

Nanexa AB 

SEK5.82
2
+SEK0.02+0.34% Thursday 15:29

Statistics

Day High
6
Day Low
5.65
52W High
6.23
52W Low
1.4
Volume
639,410
Avg. Volume
421,620
Mkt Cap
1.08B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

27AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-31.5%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
36.15MRevenue
-11.39MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. develops advanced drug delivery systems and pharmaceuticals, competing in the same sector as Nanexa.
Novartis
NVS
Mkt Cap292.35B
Novartis AG focuses on innovative pharmaceutical solutions, including drug delivery technologies similar to Nanexa's.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is involved in developing advanced drug delivery systems which align with Nanexa's business model.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceutical and biotechnology field, directly competing with Nanexa in drug delivery solutions.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. works on novel pharmaceutical formulations, competing with Nanexa in the drug delivery space.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company develops pharmaceutical products that often incorporate advanced drug delivery technologies.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb Company offers pharmaceutical products that compete with Nanexa's drug delivery technologies.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline plc engages in the creation of drug delivery systems, which pits them against Nanexa.
Sanofi
SNY
Mkt Cap107.39B
Sanofi operates globally in pharmaceuticals, including drug delivery systems that compete with Nanexa's technologies.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC specializes in biopharmaceuticals, including drug delivery systems that rival Nanexa's products.

About

Nanexa AB (publ) is a firm dedicated to developing advanced drug delivery solutions through nanotechnology. The company leverages its proprietary PharmaShell platform, a nanobased system that utilizes atomic layer deposition (ALD) technology for drug administration. Furthermore, Nanexa is progressing NEX-18, a PharmaShell-based candidate specifically designed to address severe conditions such as Myelodysplastic Syndrome and Acute Myeloid Leukemia. The company was established in 2007 and is headquartered in Uppsala, Sweden.
Show more...
CEO
David Westberg
Employees
15
Country
Sweden
ISIN
SE0007074166
WKN
000A2JA78

Listings

ST
SE
NANEXA-BTA.ST
ST
SE
NANEXA.ST
F
DE
40M.F

0 Comments

Share your thoughts

FAQ

What is Nanexa AB stock price today?▼
The current price of NANEXA.ST is SEK5.82 SEK — it has increased by +0.34% in the past 24 hours. Watch Nanexa AB stock price performance more closely on the chart.
What is Nanexa AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Nanexa AB stocks are traded under the ticker NANEXA.ST.
Is Nanexa AB stock price growing?▼
NANEXA.ST stock has risen by +19.14% compared to the previous week, the month change is a +40.41% rise, over the last year Nanexa AB has showed a +142.5% increase.
What is Nanexa AB market cap?▼
Today Nanexa AB has the market capitalization of 1.08B
What is Nanexa AB revenue for the last year?▼
Nanexa AB revenue for the last year amounts to 36.15M SEK.
What is Nanexa AB net income for the last year?▼
NANEXA.ST net income for the last year is -11.39M SEK.
How many employees does Nanexa AB have?▼
As of September 04, 2026, the company has 15 employees.
In which sector is Nanexa AB located?▼
Nanexa AB operates in the Health & Wellness sector.
When did Nanexa AB complete a stock split?▼
Nanexa AB has not had any recent stock splits.
Where is Nanexa AB headquartered?▼
Nanexa AB is headquartered in Uppsala, Sweden.